GeneralConnection.com ➔ Dictionary
Dictionary Search

hemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
New treatment for Hemophilia B brings hope to patients - FOX 2 Detroit
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
Explainer 2025 Why Is Hemophilia B Called Christmas Disease - Global Biotechnology Company
New data suggest gene therapy may reach more hemophilia B patients - Hemophilia News Today
Integrating Gene Therapy into Clinical Care for Hemophilia B - CGTLive®
Hemophilia B Pipeline Set for Transformational Breakthroughs - openPR.com
Hemophilia B Gene Therapy Continues to Reduce Bleeding - Medscape
Hemophilia Studies Today: Points of Interest - Docwire News
How durable is gene therapy for haemophilia B? - Nature
Gene therapy can help reduce joint bleeds in hemophilia B: New data - Hemophilia News Today
Single-Dose Gene Therapy Shows Promising Safety, Efficacy, and Patient-Reported Outcomes in Hemophilia B - Docwire News
Gene therapy Beqvez sustains gains in 6-year hemophilia B study - Hemophilia News Today
New gene therapy reduces bleeding rates for hemophilia B patients - Hemophilia News Today
Five-year results highlight new treatment option for hemophilia B - Hemophilia News Today
Steven W. Pipe, MD, on Integrating Gene Therapy into Clinical Care for Hemophilia B - CGTLive®
Gene therapy comes of age to staunch hemophilia B - St. Jude Children's Research Hospital
AAV Gene Therapy in Severe Hemophilia B - The New England Journal of Medicine
Utah Center for Bleeding & Clotting Disorders at University of Utah Health Administers New Gene Therapy for Hemophilia B - School of Medicine | University of Utah
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
The potential of bringing hemophilia B gene therapy to younger patients - CGTLive®
China’s first hemophilia B gene therapy now approved in Macao - Hemophilia News Today
Karmanos Cancer Institute Becomes First and Only Free-Standing Cancer Center to Treat Hemophilia B with New Gene Therapy - PR Newswire
Hemophilia B gene therapy demonstrates long-term success - St. Jude Children's Research Hospital
Distribution of people with hemophilia B in the U.S. in 2024, by age group - Statista
HOPE-B Shows Bleeding Control Still Holding at 5 Years - Docwire News
FDA may OK Hympavzi for children 6 and older with hemophilia A or B - Hemophilia News Today
Universal hope for hemophilia - The University of North Carolina at Chapel Hill
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B - The New England Journal of Medicine
Longer Follow-Up Data Reinforce Concizumab’s Efficacy in Hemophilia A and B With Inhibitors - Docwire News
Marstacimab Prophylaxis for Hemophilia With Inhibitors: BASIS Trial Adds Evidence - Docwire News
Gene Therapy Supply Runs Out, Company Warns of Treatment Delays - MedPage Today
Hemophilia B gene therapy Hemgenix to be covered in Canada - Hemophilia News Today
CSL Behring's Hemophilia B Gene Therapy Provides Bleeding Protection Out to Five Years - Precision Medicine Online
Exploring gene editing as a potential therapeutic strategy for hemophilia - Frontiers
ASH: CSL proves efficacy of hemophilia B gene therapy Hemgenix holds up after 5 years - Fierce Pharma
Hemophilia B gene therapy benefits last more than a decade: Study - Hemophilia News Today
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
(marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
First-in-human trial of hemophilia B treatment BE-101 starts dosing - Hemophilia News Today
CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix - Fierce Pharma
CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B - Yahoo Finance
How Gene Therapy Is Transforming Hemophilia B Treatment - Docwire News
HOPE-B: 5-Year Etranacogene Dezaparvovec Maintains Durable Efficacy and Safety in Hemophilia B, With Steven Pipe, MD - HCPLive
FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors - Contemporary Pediatrics
Hemophilia B: Gene Therapy Shows 5-Year Success - Medscape
CSL says hemophilia B gene therapy is temporarily out of stock, warns of treatment delays - Endpoints News
AAV gene therapy shows durable benefit in hemophilia B - 2 Minute Medicine
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors - PR Newswire
Building safeguards for gene therapy in haemophilia - The Lancet
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors - Business Wire
EAHAD 2026: Nine-Year Outcomes of Gene Therapy - EMJ
Phase 3 Study Evaluates Marstacimab for Hemophilia A, B, Without Inhibitors - Docwire News
Engineered albumin-fused FIX extends hemophilia B treatment half-life beyond standard 3–4 day window - Medical Xpress
Hemgenix (etranacogene dezaparvovec) for hemophilia - Hemophilia News Today
ASH data: Marstacimab improves bleeding outcomes in adolescents, adults with hemophilia A or B - Contemporary Pediatrics
First Patient Dosed in Clinical Trial of An Engineered B-Cell Medicine for Hemophilia B - Docwire News
FDA Approves Extended Indication for Concizumab-Mtci for Hemophilia A and B - Docwire News
Patient in Germany gets hemophilia B gene therapy Hemgenix - Hemophilia News Today
Alhemo Indication Expanded to Include Hemophilia A/B Without Inhibitors - MPR - Medical Professionals Reference
Karmanos is First Independent Cancer Center to Treat Hemophilia B with New Gene Therapy - DBusiness Magazine
Eloctate, Alprolix control bleeds in hemophilia patients’ major surgeries - Hemophilia News Today
Gene Therapy Maintains Efficacy in Hemophilia B Out to 5 Years - MedPage Today
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties - Nature
Pfizer’s Hympavzi Cuts Bleeding by 93% in Hemophilia A and B Patients with Inhibitors, Phase 3 Trial Finds - Managed Healthcare Executive
How to Plan for Emergencies When You Have Hemophilia B - Everyday Health
Hemophilia gene therapy: A new era of treatment and the obstacles ahead - Drug Discovery News
China Explores Weight-Based Pricing for First Domestic Hemophilia B Gene Therapy - NAVLIN DAILY
Encouraging Phase 3 Data Released: Marstacimab for Hemophilia A or B With Inhibitors - Docwire News
Hemophilia B Pipeline 2026 Report Highlights Next-Gen Gene - openPR.com
Spotlight on the ISTH Hemophilia Treatment Guidelines and Alternate Recommendations - Hematology Advisor
BioMarin, following sluggish sales, to offload hemophilia gene therapy - BioPharma Dive
Systemic lupus erythematosus caused acquired hemophilia B without evidence of factor IX inhibitors - Wiley Online Library
First subject dosed in Be Biopharma’s trial of haemophilia B therapy - Clinical Trials Arena
Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment - Docwire News
Children's Hospital of Philadelphia played key role in developing new treatment for hemophilia - CBS News
Extended hemophilia half-life products aid care, but raise costs - Hemophilia News Today
Massachusetts man receives groundbreaking, life-changing treatment for hemophilia B - WJAR
'Freedom From the Need': A Pharmacist's Journey From Constant Hemophilia B Treatment to Gene Therapy - Pharmacy Times
Marstacimab Improved Key Bleeding Outcomes in Hemophilia A or B - The American Journal of Managed Care
Hemophilia B Market Outlook - Grand View Research
Former Pilot Receives ‘Life-Altering’ Treatment for Longtime Condition - FLYING Magazine
Hemophilia B Market: Rapid Increment Driven by Innovation - openPR.com
G-BA Rates “Considerable” Added Benefit of Alhemo for Hemophilia B Patients - NAVLIN DAILY
Hemophilia B: Post-Beqvez, What’s Next for Gene Therapy? - Medscape
Hemophilia B Gene Therapy Sustains Efficacy Over a Decade Later - MedPage Today
Hemgenix Gene Therapy Shows Sustained Benefits Over 5 Years in Hemophilia B: NEJM - Medical Dialogues
Wolfgang Miesbach: New Study on AAV5 Antibodies in Haemophilia B Gene Therapy - Oncodaily
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - The New England Journal of Medicine
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors - BioSpace
Why Hympavzi Secured English Funding For Hemophilia B But Not Hemophilia A - Citeline News & Insights
EVOLVING THE TREATMENT LANDSCAPE WITH THE FIRST THERAPY APPROVED FOR PEOPLE WITH HEMOPHILIA A AND B WITH OR WITHOUT INHIBITORS - The American Journal of Managed Care
Pfizer's hemophilia drug Hympavzi notches phase 3 win as pharma eyes label expansion - Fierce Pharma
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B - The New England Journal of Medicine
How Fitusiran Changes the Treatment Landscape in Hemophilia: Guy Young, MD - The American Journal of Managed Care
Foreign Language Equivalents
Foreign Language Equivalents of 'hemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hemophilia ,   hemophliia b,   henophilia b,   hemophili b,   hemophulia b,   hemopihlia b,   heomphilia b,   hemophilia v,   hemophiilia b,   hemopilia b,   hemophilis b,   hhemophilia b,   hemopphilia b,   heophilia b,   he,ophilia b,   jemophilia b,   hemopjilia b,   hemophilai b,   hmophilia b,   hemophiila b,   hemophlia b,   hemoophilia b,   hmeophilia b,   hemophili ab,   hemo[hilia b,   heemophilia b,   hemophiloa b,   hemohpilia b,   ehmophilia b,   hemophiliab,   hemophilia bb,   hwmophilia b,   hempphilia b,   hemophiliaa b,   hemophhilia b,   hemophi;ia b,   hemophiliab ,   hemophilia n,   hemoohilia b,   hemophiliia b,   hrmophilia b,   emophilia b,   hemophiia b,   hemopgilia b,   hemohilia b,   hemiphilia b,   gemophilia b,   hemophilia b,   hemophila b,   hemopholia b,   hempohilia b,   hemmophilia b,   hemophillia b,   hemophikia b,   hemophilua b,   hemphilia b
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z